• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析组织微阵列数据的统计方法。

Statistical methods for analyzing tissue microarray data.

作者信息

Liu Xueli, Minin Vladimir, Huang Yunda, Seligson David B, Horvath Steve

机构信息

Department of Biostatistics, School of Public Health, UCLA, Los Angeles, California, USA.

出版信息

J Biopharm Stat. 2004 Aug;14(3):671-85. doi: 10.1081/BIP-200025657.

DOI:10.1081/BIP-200025657
PMID:15468758
Abstract

Tissue microarrays (TMAs) are a new high-throughput tool for the study of protein expression patterns in tissues and are increasingly used to evaluate the diagnostic and prognostic importance of biomarkers. TMA data are rather challenging to analyze. Covariates are highly skewed, non-normal, and may be highly correlated. We present statistical methods for relating TMA data to censored time-to-event data. We review methods for evaluating the predictive power of Cox regression models and show how to test whether biomarker data contain predictive information above and beyond standard pathology covariates. We use nonparametric bootstrap methods to validate model fitting indices such as the concordance index. We also present data mining methods for characterizing high risk patients with simple biomarker rules. Since researchers in the TMA community routinely dichotomize biomarker expression values, survival trees are a natural choice. We also use bump hunting (patient rule induction method), which we adapt to the use with survival data. The proposed methods are applied to a kidney cancer tissue microarray data set.

摘要

组织微阵列(TMAs)是一种用于研究组织中蛋白质表达模式的新型高通量工具,并且越来越多地用于评估生物标志物在诊断和预后方面的重要性。TMA数据的分析颇具挑战性。协变量高度偏态、非正态,且可能高度相关。我们提出了将TMA数据与删失的事件发生时间数据相关联的统计方法。我们回顾了评估Cox回归模型预测能力的方法,并展示了如何检验生物标志物数据是否包含超出标准病理协变量的预测信息。我们使用非参数自助法来验证诸如一致性指数等模型拟合指标。我们还提出了用于通过简单生物标志物规则来表征高危患者的数据挖掘方法。由于TMA领域的研究人员通常将生物标志物表达值二分,生存树是一个自然的选择。我们还使用了凸点搜索法(患者规则归纳法),并将其适用于生存数据。所提出的方法应用于一个肾癌组织微阵列数据集。

相似文献

1
Statistical methods for analyzing tissue microarray data.分析组织微阵列数据的统计方法。
J Biopharm Stat. 2004 Aug;14(3):671-85. doi: 10.1081/BIP-200025657.
2
Tissue microarrays: emerging standard for biomarker validation.组织微阵列:生物标志物验证的新兴标准。
Curr Opin Biotechnol. 2008 Feb;19(1):19-25. doi: 10.1016/j.copbio.2007.10.009. Epub 2007 Dec 3.
3
Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.挖掘组织微阵列数据,揭示生物标志物表达模式的组合,以改善透明细胞肾细胞癌的中间分期和分级。
Clin Cancer Res. 2010 Jan 1;16(1):88-98. doi: 10.1158/1078-0432.CCR-09-0260. Epub 2009 Dec 22.
4
[Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma].组织芯片在肾细胞癌诊断、预后及治疗决策中的应用
Urologe A. 2006 Mar;45(3):323-4, 326-7. doi: 10.1007/s00120-006-1005-y.
5
Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.外周血单个核细胞中的转录谱对晚期肾细胞癌患者临床结局的预后价值
Clin Cancer Res. 2005 Feb 1;11(3):1181-9.
6
Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.基于TNM分类的肾细胞癌术前预后列线图(概率表)。
J Urol. 2009 Feb;181(2):480-5; discussion 485. doi: 10.1016/j.juro.2008.10.017. Epub 2008 Dec 19.
7
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.肾切除术后非转移性肾细胞癌四种预后模型预测准确性的比较:一项欧洲多中心研究
Cancer. 2005 Oct 1;104(7):1362-71. doi: 10.1002/cncr.21331.
8
Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.原发性肾细胞癌内p27(Kip1)表达的异质性、其浸润边缘和瘤旁肾实质与病理及预后特征的相关性。
Urol Int. 2007;79(2):164-9. doi: 10.1159/000106332.
9
TmaDB: a repository for tissue microarray data.TmaDB:一个组织微阵列数据存储库。
BMC Bioinformatics. 2005 Sep 1;6:218. doi: 10.1186/1471-2105-6-218.
10
[DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].[DNA和微小RNA微阵列技术在肾细胞癌患者诊断和预测中的应用]
Klin Onkol. 2009;22(5):202-9.

引用本文的文献

1
An Application of the Patient Rule-Induction Method to Detect Clinically Meaningful Subgroups from Failed Phase III Clinical Trials.患者规则归纳法在从失败的III期临床试验中检测具有临床意义亚组中的应用。
Int J Clin Biostat Biom. 2021;7(1). doi: 10.23937/2469-5831/1510038. Epub 2021 Jun 28.
2
Applications and continued evolution of glycan imaging mass spectrometry.聚糖成像质谱技术的应用和持续发展。
Mass Spectrom Rev. 2023 Mar;42(2):674-705. doi: 10.1002/mas.21725. Epub 2021 Aug 15.
3
Utility of histone H3K27me3 and H4K20me as diagnostic indicators of melanoma.
组蛋白 H3K27me3 和 H4K20me 作为黑色素瘤诊断标志物的效用。
Melanoma Res. 2020 Apr;30(2):159-165. doi: 10.1097/CMR.0000000000000648.
4
Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer.适应性RSK-EphA2-GPRC5A信号转导开关触发卵巢癌的化疗耐药性。
EMBO Mol Med. 2020 Apr 7;12(4):e11177. doi: 10.15252/emmm.201911177. Epub 2020 Mar 2.
5
Learning rule sets from survival data.从生存数据中学习规则集。
BMC Bioinformatics. 2017 May 30;18(1):285. doi: 10.1186/s12859-017-1693-x.
6
Patient subgroup identification for clinical drug development.用于临床药物开发的患者亚组识别
Stat Med. 2017 Apr 30;36(9):1414-1428. doi: 10.1002/sim.7236. Epub 2017 Feb 1.
7
TMAinspiration: Decode Interdependencies in Multifactorial Tissue Microarray Data.TMA灵感:解码多因素组织微阵列数据中的相互依存关系。
Cancer Inform. 2016 Jun 29;15:143-9. doi: 10.4137/CIN.S39112. eCollection 2016.
8
Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.雌激素受体-β和胰岛素样生长因子-2在三阴性乳腺癌中的生物学作用。
Biomed Res Int. 2015;2015:925703. doi: 10.1155/2015/925703. Epub 2015 Mar 22.
9
Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.通过全基因组表达微阵列鉴定出的肾上腺皮质癌中过表达基因的免疫组织化学验证揭示了潜在的预测性和预后生物标志物。
Oncologist. 2015 Mar;20(3):247-56. doi: 10.1634/theoncologist.2014-0392. Epub 2015 Feb 5.
10
A PRIM approach to predictive-signature development for patient stratification.一种用于患者分层的预测性特征开发的PRIM方法。
Stat Med. 2015 Jan 30;34(2):317-42. doi: 10.1002/sim.6343. Epub 2014 Oct 27.